/PRNewswire/ As we approach the end of celebrating Women s History Month, the Pharmaceutical Research and Manufacturers of America is taking a closer look.
Note: Thank you to Dr. Moskowitz for this insightful look into Covid. I think Dan Olmsted would be smiling down on us today. We are running A Plague on Both Your Houses in two parts this week. There might be.
Concert Genetics and Trapelo Health Partner to Advance Molecular Oncology Decision Support
Partnership Seeks to Lower Barriers to Evidence-Based Molecular Oncology Care by Extending Trapelo s Decision Support Solutions Through Concert s Network of Laboratories and Health Plans
News provided by
Share this article
Share this article
BURLINGTON, Mass. and NASHVILLE, Tenn., Dec. 10, 2020 /PRNewswire/ Concert Genetics and Trapelo Health announced today that they have partnered to provide a streamlined, integrated solution that will expand access to evidence-based, genomic-informed oncology decision support.
(PRNewsfoto/Trapelo Health)
The partnership is built on a shared mission to improve connectivity, transparency, and alignment among the healthcare stakeholders that support the delivery of oncology care. It combines the unique strengths of the two organizations: Concert s genetic testing data and digital infrastructure and Trapelo s expertise in molecular oncology decision s